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1420Objective: The Ross procedure is widely used for aortic valve disease in patients who are still growing and young
adults with active lifestyles or the desire for pregnancy. The need for autograft reoperation remains the principal
limitation of the procedure. Autograft inclusion in a polyester tube prosthesis has been proposed with good post-
operative results, but the durability of these technical modifications has not been assessed. We report the midterm
results of pulmonary autograft reinforcement with a Valsalva Gelweave Dacron tube (Terumo Cardiovascular
Systems Inc, Ann Arbor, Mich).
Methods: Since 1992, we have performed 322 Ross operations; 12 patients underwent a modified Ross procedure
with the autograft included in a Valsalva Gelweave Dacron tube. The mean age of these patients was 29.7 10.8
years (range, 15.3–46.5 years). The mean aortic crossclamp time was 126  11 minutes (range, 110–142
minutes). The mean follow-up was 4  1.4 years (range 1.7–5.8 years).
Results:No perioperative deaths were observed, and all patients are alive and doing well. No significant autograft
regurgitation was recorded during follow-up. The mean diameters of the autograft annulus and the neosinus of
Valsalva were 23.3  2.6 mm and 32.6  3.3 mm, respectively, at discharge, and 24.0  1.9 mm and 33.6 
3.3 mm, respectively, at the last control (P ¼ .32 and P ¼ .08, respectively).
Conclusion: These results support that this technical modification of the Ross operation might be proposed for
patients at risk of autograft dilatation when an inclusion technique is not feasible. (J Thorac Cardiovasc Surg
2010;139:1420-3)Replacement of the aortic valve or aortic root with a pulmo-
nary autograft (Ross procedure) provides a viable valve with
potential advantages, including excellent hemodynamic
function, ability to grow, and durability with no need for
anticoagulation. The procedure is widely used for aortic
valve disease in growing patients and young adults with
an active lifestyle or a desire to become pregnant. Excellent
short- and mid-term results have been demonstrated with
low operative mortality and low rates of valve-related deaths
or complications.
However, concern has been raised about the ability of the
pulmonary autograft to adapt to the high-pressure systemic
circulation. Progressive dilatation of the neosinuses of Val-
salva occurs in 10% to 30% of late survivors, especially
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The Journal of Thoracic and Cardiovascular Suris used, and often leads to autograft insufficiency.1,2 The
need for autograft reoperation remains the principal
limitation of the procedure. Stabilization of the autograft
annulus and autograft sinotubular junction may prevent the
dilatation of these sites, but not the aneurysmal evolution
of autograft sinuses of Valsalva. Autograft inclusion in
a polyester tube prosthesis has been proposed with good
postoperative results, but the durability of this technical
modification has not been assessed.3-6 We previously
published a report on the use of a Valsalva Gelweave
Dacron tube (Vascutek Gelweave Valsalva Grafts; Terumo
Cardiovascular Systems Inc, Ann Arbor, Mich) in the
Ross operation.6 We report the midterm results of our mod-
ification of the Ross procedure with the pulmonary autograft
implanted in a Valsalva Gelweave Dacron tube allowing
preservation of the end-systolic leaflet motion.MATERIALS AND METHODS
Patient Population
Since 1992, we have performed 322 Ross operations in adult and pedi-
atric patients. During a mean follow-up of 8  4.9 years, 15 patients have
undergone reoperation because of autograft dilatation (4.7%). Autografts
were implanted in 266 patients by using the freestanding root replacement
technique, in 10 patients by using the subcoronary implantation technique,
and in 46 patients by using the inclusion technique (native aorta or Valsalva
graft). All operations were performed by the same surgeon (A.P.)
BetweenMarch 2003 andMarch 2007, 12 patients underwent a modified
Ross procedure with the autograft included in a Valsalva Gelweave Dacrongery c June 2010
FIGURE 1. Operative technique. A, Proximal suture between the autograft
and the polyester tube. B, Neoaortic root after proximal anastomosis.
C, Detail of the left coronary artery anastomosis.
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Dtube. The mean age of these patients was 29.7  10.8 years (range, 15.3–
46.5 years). There were 8 male patients. A bicuspid aortic valve was present
in all cases. Four patients had a concomitant aneurysm of the ascending
aorta. All patients had isolated aortic regurgitation, and 2 patients had infec-
tive endocarditis (1 acute, 1 active). One patient had a history of surgical
reparation of isthmic coarctation. All patients were preoperatively in New
YorkHeart Association functional class II. The left ventricular ejection frac-
tion was 50% or more in all but 1 patient (30%).
Operative Procedure
Operations were performed under normothermic cardiopulmonary
bypass with intermittent antegrade cold blood cardioplegia (Figure 1).
The diseased aortic valve was excised. The coronary ostia were reimplanted
with the so-called button technique, which consists of totally excising
a small (8–9 mm) cut of the aortic wall containing the coronary ostium.
The pulmonary autograft was harvested, and its diameter was measured.
Excess adventitial autograft tissue was removed, and the entire autograft
was placed inside a Valsalva Gelweave Dacron tube. The selected prosthetic
tube diameter was 4 mm greater than the measured autograft inner diameter
because of the thickness of the muscle rim at the inferior aspect of the auto-
graft. The pulmonary autograft annulus was proximally sewn to the prosthe-
sis with a 4-0 polypropylene (Ethicon, Inc, Somerville, NJ) running suture.
The length of the Dacron tube was then tailored to exactly fit the height of
the pulmonary autograft, and the distal end of the autograft was sutured to
the Dacron tube with a 4-0 polypropylene running suture. Both sutures were
facilitated by placing a Hegar dilator through the autograft lumen.
The pulmonary autograft supported with the Dacron prosthesis was then
sutured to the aortic annulus in a horizontal plane using separate 3-0 Ethi-
bond (Ethicon, Inc) sutures. The autograft was positioned so that the left
and right coronary arteries matched the corresponding sinuses of the ‘‘neo-
aortic root.’’ Two large windows were created in the prosthetic tube at the
site dedicated to the coronary artery button anastomosis. The left coronary
artery was reimplanted first using a 6-0 polypropylene running suture. The
distal anastomosis between the autograft/Dacron and the ascending aorta
was performed with a 5-0 polypropylene running suture. Finally, the right
coronary artery anastomosis was performed after filling the aortic root
with cardioplegia. The coronary buttons were reimplanted in the autograft
wall only, through slightly larger ‘‘button-holes’’ made in the vascular graft,
to prevent blood accumulation between the autograft and the prosthesis that
could lead to valvular or coronary incompetence.
Reconstruction of the right ventricular outflow tract was performed with
a cryopreserved pulmonary homograft (European Homograft Bank, Brus-
sels, Belgium) in 9 patients and with a stentless porcine root in 3 patients.
Postoperative Echocardiography
Comprehensive transthoracic echocardiography was performed at dis-
charge, 6 months, 12 months, and then yearly. The echocardiographic ex-
amination included a morphologic analysis of the composite ‘‘pulmonary
autograft/Dacron tube’’ with measurements of the autograft annulus, neosi-
nuses of Valsalva, and sinotubular junction diameters. Mean and peak gra-
dients across the pulmonary autograft (aortic position) and allograft
(pulmonary position) were measured with the use of continuous-wave
Doppler. Autograft and homograft regurgitation were semiquantitatively as-
sessed and classified according to a 4-grade scale. Serial echocardiographic
studies were available for 12 patients.
Statistical Analysis
Statistical analysis was performed using the SAS system (SAS v8, SAS
Institute Inc, Cary, NC). Continuous variables are described as mean stan-
dard deviation, and categoric variables are described as frequencies or pro-
portions.
Evolution of the neoaortic root diameters and the gradients across the
pulmonary autograft and allograft were tested with paired Student t testsdiovascular Surgery c Volume 139, Number 6 1421
TABLE 1. Hemodynamic results
Discharge (mm Hg) Last control (mm Hg) P
Mean Peak Mean Peak Mean/peak
Autograft 4.7  2.4 8.2  4.3 4.7  3.4 8.9  6.2 .6/.7
Homograft 3.8  2.7 7.8  5.8 7.5  4.7 14.4  7.5 .02/.004
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Dor Wilcoxon signed-rank tests, depending on the normality of the data,
tested beforehand with Shapiro–Wilk tests.
Results are expressed as mean values standard deviation. Paired t test-
ing was used to determine changes in the diameter of the neoaortic root.RESULTS
The mean aortic crossclamp time was 126  11 minutes
(range, 110–142 minutes). The mean cardiopulmonary by-
pass time was 149  23 minutes (range, 128–212 minutes).
The mean follow-up was 4  1.4 years (range, 1.7–5.8
years). No perioperative deaths were observed, and all pa-
tients were alive and doing well at the last visit. No throm-
boembolic events occurred during follow-up. Endocarditis
did not develop in any of the patients.Reoperation
Two patients required nonvalvular reoperation during the
follow-up.
The first patient underwent reoperation 3 months postop-
eratively. Briefly, he had a history of factor V Leiden. An
intra-atrial mass was discovered 1 month after surgery and
persisted despite anticoagulant treatment. The patient under-
went reoperation because of his hemostatic risk factors, and
an inverted left atrial appendage was found, which was re-
sected.6
The second patient presented with a false aneurysm on the
proximal suture line of the autograft 6 months postopera-
tively. The false aneurysm was successfully repaired with
preservation of the autograft.Echocardiographic Studies
Autograft and homograft function. At discharge, no pa-
tient had a significant autograft or homograft regurgitation
or stenosis. At the latest follow-up, a mild autograft regurgi-
tation was detected in 1 patient; no patient had homograft re-
gurgitation. The hemodynamic results are listed in Table 1.
Autograft dimension. Themean autograft diameters at dis-
charge and at the latest examination are shown in Table 2.TABLE 2. Echocardiographic autograft diameter
Measurement level Discharge (mm) Last control (mm) P
Annulus 23.3  2.6 24.0  1.9 .32
Neosinuses 32.6  3.3 33.6  3.3 .08
Sinotubular junction 28.9  4.5 29.5  3.6 .25
1422 The Journal of Thoracic and Cardiovascular SurThere was no significant change over time in the mean
dimension of the autograft at each measurement level.
DISCUSSION
The Ross operation was originally performed by implant-
ing the autograft inside the aortic root in the subcoronary po-
sition;7 at that time, the entire root was implanted inside the
aortic root. In the 1990s, the freestanding autograft root
replacement technique became the technique of choice be-
cause it was associated with a lower risk of early autograft
insufficiency and failure.8,9 But long-term results have
shown that the freestanding autograft root replacement tech-
nique is associated with a higher risk of autograft dilatation
and autograft insufficiency. Moreover, dilated autograft dis-
section has been reported.10
Many explanations for the development of autograft aneu-
rysms have been proposed, including blaming the structural
weakness of human pulmonary roots in adults (media layer
thickness and fragmentation) and the deleterious effects of
pulmonary autograft devascularization.11 The Toronto
group has also demonstrated that aortic bicuspid valve dis-
ease, which is a common indication for the Ross operation
(in our experience 225/322 cases; 69.8%), is often associ-
ated with histologic abnormalities of both the ascending
aorta and the pulmonary artery media layer, which could ex-
plain the autograft’s inability to sustain the high pressure in
the systemic circulation.12
In a recent meta-analysis, Takkenberg and colleagues13
found that failure rate of the autograft was higher in children
than in young adults. The pooled autograft deterioration lin-
earized rates were 1.15% per year in consecutive series of
children and adults, 0.78% per year in adult patient series,
and 1.38% per year in pediatric series. The need for auto-
graft reoperation remains the principal limitation of the
Ross procedure. Elkins and colleagues14 recently showed
that preoperative aortic insufficiency and male gender
were predictors of postoperative autograft regurgitation. Da-
vid15 reported the same experience and does not recommend
performing a Ross operation in young male adults with pre-
operative aortic insufficiency and aortic annulus dilatation.
For these patients, several groups have proposed technical
modifications of the freestanding autograft root replacement
technique to avoid autograft dilatation. External stabilization
of the autograft annulus and sinotubular junction with Teflon
felt or pericardium has been proposed because dilatation at
these levels was proved to be rapidly associated withgery c June 2010
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prevent dilatation of the neosinuses of Valsalva. Other au-
thors described early promising results with another techni-
cal modification, consisting of externally wrapping the entire
autograft with a tubular polyester graft. However, leaflet
end-systolic motion is not preserved and long-term root
and valve function could be altered by the rigidity of this
double aortic wall layer.3,5
The modification we describe in this report with the use of
a Valsalva Gelweave Dacron tube has the advantage of re-
producing the natural geometry of the native aortic root
and allowing complete autograft leaflet motion. This has
been demonstrated in the case of aortic valve sparing opera-
tion.16 Conversely, Sievers and colleagues17 chose to return
to the original Ross procedure (subcoronary or cylinder in-
clusion technique) with excellent results, which is the cur-
rent policy in Cardiologic University Hospital, Lille,
France. However, this is not feasible in some cases: The cyl-
inder inclusion technique is difficult to perform in cases of
significant aortic-pulmonary root mismatch. Similarly,
some patients with bicuspid aortic valves have a major dys-
symmetry between the 2 leaflets, and in such cases subcoro-
nary grafting is not feasible. The subcoronary technique is
also contraindicated in the case of a large aneurysm of the
ascending aorta extending to the sinuses of Valsalva. In
these patients, freestanding aortic root replacement is still
the standard. We developed our technical modification
mainly for those patients with previously identified risk fac-
tors for autograft dilatation.14 One of the main interests of
the Ross operation in a pediatric population is certainly the
growth potential of the pulmonary autograft, which would
be prohibited if the autograft is included in a prosthetic ma-
terial. In this series of 12 patients, the youngest (2 patients)
were both 15 years old and the dimensions of their aortic an-
nuli were 23 and 26 mm. We believe that an aortic annulus
less than 20 mm should preclude the use of a Valsalva graft
inclusion technique, and in this case we would always rec-
ommend an inclusion technique or a freestanding root re-
placement in case of aortic root anatomy abnormalities.The Journal of Thoracic and CarCONCLUSIONS
Our results show that the neoaortic root function and size
remained satisfactory for up to 5.8 years of follow-up; thus,
this technical modification of the Ross operation might be
proposed for patients at risk of autograft dilatation when
an inclusion technique is not feasible.
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